WHO ICTRP trial
Study on intravenous fluids in dengue shock
CTRI/2023/11/060213 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/11/060213 |
|---|---|
| Public title | Study on intravenous fluids in dengue shock |
| Scientific title | Standard therapy versus PLasmalyte In children with Dengue Shock Syndrome (SPLID TRIAL): an open labelled randomised control trial - nil |
| Primary sponsor | Indian Council of Medical Research |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: A91- Dengue hemorrhagic fever |
| Interventions | Intervention1: Plasmalyte: Children in PL/NS/RL group will be started with 10-20ml/kg bolus of study fluid(4,6) in initial 30 mins, if the hematocrit falls, pulse rate and blood pressure stable and urine output between 0.5 to 1 ml/kg/hr… |
| Registration date | Nov 23, 2023 |
| Target size | 135 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: